- Home
- ZVIA vs VANI Comparison
ZVIA vs VANI Comparison
Compare ZVIA & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVIA | VANI |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.4M | 95.8M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ZVIA | VANI |
|---|---|---|
| Price | $1.20 | $0.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $4.93 | $4.00 |
| AVG Volume (30 Days) | ★ 533.8K | 189.8K |
| Earning Date | 05-06-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $161,259,000.00 | $4,000,000.00 |
| Revenue This Year | $8.33 | N/A |
| Revenue Next Year | $6.84 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 4.01 | N/A |
| 52 Week Low | $1.11 | $0.91 |
| 52 Week High | $3.66 | $1.92 |
Technical Indicators
Market Signals| Indicator | ZVIA | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 36.11 | 26.88 |
| Support Level | $1.11 | N/A |
| Resistance Level | $2.76 | $1.26 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 28.85 | 3.74 |
Price Performance
Historical ComparisonAbout ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.